Prothena | PRTA - Trade Creditors


Prothena reported $4.3M in Trade Creditors for its fiscal quarter ending in March of 2026.





Trade Creditors Change Date
Acadia Pharmaceuticals USD 12.25M 1.34M Mar/2026
Agios Pharmaceuticals USD 13.75M 4.61M Mar/2026
Akebia Therapeutics USD 8.39M 12.8M Mar/2026
ALKERMES USD 102.36M 5.59M Mar/2026
Alnylam Pharmaceuticals USD 126.63M 10.91M Mar/2026
Amgen USD 19.52B 1.37B Mar/2026
Biogen USD 358.5M 73.5M Mar/2026
BioMarin Pharmaceutical USD 793.15M 34.12M Mar/2026
Exelixis USD 24.15M 5.47M Mar/2026
Immunic USD 11.01M 873K Mar/2026
Incyte USD 228.62M 1.41B Mar/2026
Ionis Pharmaceuticals USD 26.03M 2.05M Mar/2026
MacroGenics USD 4.29M 500K Mar/2026
Nektar Therapeutics USD 10.77M 4.79M Dec/2025
Neurocrine Biosciences USD 691.3M 145.8M Mar/2026
Prothena USD 4.3M 1.58M Mar/2026
Regeneron Pharmaceuticals USD 1.03B 4.81B Mar/2026
Ultragenyx Pharmaceutical USD 42M 11M Mar/2026
Vertex Pharmaceuticals USD 3.47B 40.6M Mar/2026
Xoma USD 2.65M 1.52M Sep/2025